引领生物医用材料特色产业发展！中国药谷工信部“揭榜挂帅”企业+1

Core Insights - The Ministry of Industry and Information Technology and the National Medical Products Administration have announced the second batch of companies selected for the "Innovative Task of Biomedical Materials" initiative, with 14 companies from Beijing, including AoJing Medical Technology Co., Ltd. recognized for its "degradable semi-hydrated calcium sulfate" medical material [1][7] Company Overview - AoJing Medical is focused on the research, development, production, and sales of implantable medical devices for tissue regeneration and repair. The company pioneered the development of mineralized collagen biomimetic bone materials that closely resemble natural human bone tissue in composition and structure, achieving clinical transformation and industrialization [2][4] - The mineralized collagen biomimetic bone material consists of collagen and mineral components, such as hydroxyapatite, offering excellent biocompatibility and mechanical properties. It has been used in over one million clinical cases, demonstrating significant effectiveness in bone defect repair and regeneration [2][4] Industry Development - The Daxing Biomedical Industry Base is actively promoting the construction of specialized industrial parks, focusing on key technology research and development in high polymer materials, metal materials, and inorganic non-metallic materials [4][11] - The "Innovative Task of Biomedical Materials" initiative aims to address critical challenges in the industry, with selected companies receiving support in financing and regulatory reviews to accelerate technology transfer and application [11] - The Daxing Biomedical Industry Base has been officially named the "Zhongguancun (Daxing) Biomedical Materials Industrial Park," emphasizing its role in integrating medical and engineering sectors and fostering innovation in biomedical materials and medical devices [9][11]